Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Endo EBITDA 2024-2025 | NDOI

Endo ebitda from 2024 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
  
Endo Annual EBITDA
(Millions of US $)
2024 $-236
2023 $-923
2022 $175
Endo Quarterly EBITDA
(Millions of US $)
2025-03-31 $-7
2024-12-31 $-79
2024-09-30 $-115
2024-06-30 $-181
2024-03-31 $138
2023-09-30 $117
2023-06-30 $119
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.603B $1.178B
Endo Inc. is a diversified pharmaceutical company. Endo Inc. is based in MALVERN, Pa.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Zoetis (ZTS) United States $70.463B 26.29
Takeda Pharmaceutical (TAK) Japan $48.143B 9.58
Daiichi Sankyo, - (DSNKY) Japan $41.714B 21.38
BeOne Medicines - (ONC) Cayman Islands $28.024B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.636B 0.00
Summit Therapeutics (SMMT) United States $18.374B 0.00
Merck (MKKGY) Germany $16.944B 12.41
Shionogi (SGIOY) Japan $14.321B 14.35
United Therapeutics (UTHR) United States $13.557B 11.99
Neurocrine Biosciences (NBIX) United States $13.213B 45.26
Orion OYJ (ORINY) Finland $10.673B 28.86
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.650B 46.78
Corcept Therapeutics (CORT) United States $7.518B 61.11
Madrigal Pharmaceuticals (MDGL) United States $6.852B 0.00
Ionis Pharmaceuticals (IONS) United States $6.817B 0.00
Grifols, S.A (GRFS) Spain $6.456B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Soleno Therapeutics (SLNO) United States $4.459B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.638B 9.24
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.611B 14.12
NewAmsterdam Pharma (NAMS) Netherlands $2.430B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.896B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.874B 0.00
ARS Pharmaceuticals (SPRY) United States $1.758B 0.00
Ocular Therapeutix (OCUL) United States $1.714B 0.00
Evotec AG (EVO) Germany $1.474B 0.00
Guardian Pharmacy Services (GRDN) United States $1.335B 0.00
ProKidney (PROK) United States $1.270B 0.00
Harrow (HROW) United States $1.161B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.134B 22.68
Ardelyx (ARDX) United States $1.101B 0.00
Enliven Therapeutics (ELVN) United States $1.059B 0.00
Akebia Therapeutics (AKBA) United States $1.048B 0.00
Collegium Pharmaceutical (COLL) United States $1.040B 5.61
Dyne Therapeutics (DYN) United States $1.009B 0.00
Verve Therapeutics (VERV) United States $0.989B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.924B 0.00
Xeris Biopharma Holdings (XERS) United States $0.835B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
KalVista Pharmaceuticals (KALV) United States $0.795B 0.00
Xencor (XNCR) United States $0.664B 0.00
Relay Therapeutics (RLAY) United States $0.653B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.645B 0.00
Zevra Therapeutics (ZVRA) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
USANA Health Sciences (USNA) United States $0.610B 13.26
Bioventus (BVS) United States $0.601B 15.25
Theravance Biopharma (TBPH) United States $0.580B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.493B 10.30
Tourmaline Bio (TRML) United States $0.443B 0.00
Savara (SVRA) United States $0.410B 0.00
Aquestive Therapeutics (AQST) United States $0.398B 0.00
Altimmune (ALT) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.340B 9.20
Heron Therapeutics (HRTX) United States $0.340B 0.00
AleAnna (ANNA) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 26.83
Nektar Therapeutics (NKTR) United States $0.290B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.282B 0.00
Aldeyra Therapeutics (ALDX) United States $0.271B 0.00
OmniAb (OABI) United States $0.269B 0.00
Nanobiotix S.A (NBTX) France $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.244B 0.00
MediWound (MDWD) Israel $0.224B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
China SXT Pharmaceuticals (SXTC) China $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.205B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.167B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.150B 0.00
Avita Medical (RCEL) United States $0.149B 0.00
Galectin Therapeutics (GALT) United States $0.142B 0.00
Korro Bio (KRRO) United States $0.138B 0.00
Liminatus Pharma (LIMN) United States $0.136B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.130B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Champions Oncology (CSBR) United States $0.123B 20.25
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.071B 0.00
VAXART, INC (VXRT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.068B 0.00
PMV Pharmaceuticals (PMVP) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.28
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
FibroGen (FGEN) United States $0.025B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.09
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.85
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00